Objective: The development of a generalizable, fast, effective, scalable, translatable and economic purification platform is critical for the technical and economic success of mRNA-based therapeutics.
Although Bayesian Optimization (BO) has been employed for accelerating materials design in computational materials engineering, existing works are restricted to problems with quantitative variables.